Medicare Enrolled
Dr. David Gryboski, M.D.
Gastroenterology · Fayetteville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gryboski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gryboski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gryboski
Dr. David Gryboski is a gastroenterology specialist in Fayetteville, GA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Gryboski performed 4,497 Medicare services across 2,924 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gryboski received a total of $4,415 from 46 pharmaceutical and/or device companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gryboski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 2% volume in GA
$4,415 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,497
Medicare services
Top 2% in GA for gastroenterology
2,924
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~214 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue pathology examination, moderate complexity A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue. |
1,825 | $26 | $190 |
| Colon polyp removal with endoscope and cautery This procedure removes polyps or growths from the large bowel using a flexible tube with a camera. Electrical cautery is used to stop bleeding during the removal. |
540 | $137 | $1,146 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
430 | $45 | $874 |
| Special tissue stain and interpretation A laboratory test using special stains to examine tissue samples, including the pathologist's review and written report of the findings. |
406 | $56 | $190 |
| Special stain test for organisms A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results. |
237 | $69 | $189 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
208 | $209 | $1,086 |
| Esophageal dilation with guide wire and endoscope A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage. |
197 | $115 | $894 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
161 | $94 | $272 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
105 | $66 | $1,033 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
62 | $63 | $183 |
| External hemorrhoid removal by rubber banding A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off. |
50 | $216 | $688 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $111 | $520 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
42 | $101 | $1,800 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
38 | $101 | $348 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
38 | $93 | $265 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $138 | $366 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
30 | $183 | $806 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $51 | $235 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
26 | $148 | $808 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$4,415
Total received (2018-2024)
Avg $631/year across 7 years
Top 43% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
290
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,189 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$226 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,099
2023
$710
2022
$565
2021
$238
2020
$330
2019
$957
2018
$518
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$254
Takeda Pharmaceuticals U.S.A., Inc.
$141
Gilead Sciences, Inc.
$128
QOL Medical, LLC
$74
Regeneron Healthcare Solutions, Inc.
$72
Janssen Biotech, Inc.
$67
Madrigal Pharmaceuticals
$59
Merck Sharp & Dohme LLC
$46
Organon Llc
$43
Lilly USA, LLC
$38
Celgene Corporation
$33
Phathom Pharmaceuticals, Inc.
$30
Boston Scientific Corporation
$30
Ipsen Biopharmaceuticals, Inc
$19
Olympus America Inc.
$18
Fresenius Kabi USA, LLC
$17
Braintree Laboratories, Inc.
$15
Ferring Pharmaceuticals Inc.
$13
Top 3 companies account for 47.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$566
Takeda Pharmaceuticals U.S.A., Inc.
$559
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$411
Braintree Laboratories, Inc.
$253
AbbVie, Inc.
$248
Janssen Biotech, Inc.
$245
Gilead Sciences, Inc.
$225
AbbVie Inc.
$175
Ironwood Pharmaceuticals, Inc
$170
Romark Laboratories, LC
$146
Regeneron Healthcare Solutions, Inc.
$125
Ferring Pharmaceuticals Inc.
$114
Intercept Pharmaceuticals, Inc.
$107
Celgene Corporation
$97
Daiichi Sankyo Inc.
$85
QOL Medical, LLC
$74
PENTAX of America, Inc.
$60
Madrigal Pharmaceuticals
$59
Merck Sharp & Dohme LLC
$46
Organon Llc
$43
Boston Scientific Corporation
$41
Lilly USA, LLC
$38
Allergan Inc.
$38
Amgen Inc.
$35
Fresenius Kabi USA, LLC
$32
Phathom Pharmaceuticals, Inc.
$30
Organon LLC
$30
PFIZER INC.
$30
E.R. Squibb & Sons, L.L.C.
$29
INTERCEPT PHARMACEUTICALS, INC.
$28
IRONWOOD PHARMACEUTICALS, INC
$27
Merck Sharp & Dohme Corporation
$26
Shire North American Group Inc
$25
PENTAX OF AMERICA, INC.
$20
Ipsen Biopharmaceuticals, Inc
$19
Olympus America Inc.
$18
Synergy Pharmaceuticals Inc
$16
Nestle HealthCare Nutrition Inc.
$16
BOSTON SCIENTIFIC CORPORATION
$16
Esperion Therapeutics, Inc.
$15
AstraZeneca Pharmaceuticals LP
$15
Shionogi Inc
$13
Prometheus Laboratories Inc.
$13
Allergan, Inc.
$12
Alfasigma USA, Inc.
$11
Alexion Pharmaceuticals, Inc.
$11
Top 3 companies account for 34.8% of all-time payments
Associated products mentioned in payments ›
ALINIA · AVSOLA · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CLENPIQ · CREON · Creon · DIFICID · DUPIXENT · Dexilant · ENTYVIO · Entyvio · Epclusa · GASTROINTESTINAL VIDEOSCOPE · GATTEX · GENERAL POLYPECTOMY · GENERAL - HEMOSTASIS · HADLIMA · HUMIRA · Humira · IDACIO · IMAGINA · INJECTAFER · IQIRVO · Imagina · LINZESS · Linzess · MAVYRET · MOTOFEN · MOVANTIK · MOVIPREP · Mavyret · Motegrity · Mulpleta · NEXLETOL · OCALIVA · OMVOH · PENTAX · REBYOTA · RELISTOR ORAL · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUFLAVE · SUPREP BOWEL PREP · SUTAB · TREMFYA · TRULANCE · Trulance · Ultomiris · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
93
Per 100K population
77.1
County median income
$108,986
Nearest hospital
PIEDMONT FAYETTE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gryboski is a mixed practice specialist, with above-average Medicare volume (top 2% in GA), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gryboski experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Gryboski performed 1,825 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gryboski receive payments from pharmaceutical companies?
Yes. Dr. Gryboski received a total of $4,415 from 46 companies across 290 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gryboski's costs compare to other gastroenterologists in Fayetteville?
Dr. Gryboski's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gryboski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Fayetteville
Browse gastroenterologists in Fayetteville ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in GA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in GA
Which GA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology